Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07543965 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Cohort of Repeat Donor Experiences (CORE) Study

Study acronym: CORE
StatusNot Yet Recruiting
PhaseNot specified
SponsorWestat
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Westat
6 trials monitored
See 1 trial at risk
The Plasma Protein Therapeutics Association (PPTA) sponsors the Cohort of Repeat Donor Experiences (CORE) Study. This is a prospective, observational cohort study that will follow Source Plasma donors for up to 2 years during the main study (anticipated to begin in summer 2026) and up to 3 months during the pilot launching in mid-March 2026. This study aims to confirm a lack of negative health effects Source Plasma donors may experience as a result of frequent plasmapheresis. The study will use data obtained through self-report surveys for the duration of the study along with periodic whole blood sample collections to test for CRP, ferritin, and IgG.
Trial Details
NCT Number NCT07543965
Lead Sponsor Westat
Collaborators: Plasma Protein Therapeutics Association
Conditions Health Effects (Ferritin Levels, CRP Levels, iGg Levels, Self-reported Health)
Enrollment 2,090 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov